Digital Pathology Consultants welcomes Steve Potts, PhD as a new author to our blog.  Steve is a well-known and respected digital pathology veteran, and we look forward to his advice and insights!

Steven Potts recently joined Flagship Biosciences as Chief Executive Officer.  Steve has extensive experience in digital pathology, both at Aperio Technologies and previously at Quest Diagnostics Nichols Institute. He has worked for the last three years managing the biopharma business for Aperio, initiating and leading the work in GLP compliance and angiogenesis measurement, and in the development of standards for whole slide imaging in biopharmaceutical preclinical and clinical trials applications.